First, GLP1R agonists have been associated with the over-activation of GSK3β (glycogen synthase kinase-3β) in a depression model of chronic corticosterone (CORT) administration in mice, suggesting a potential link between GLP1R signaling and GSK3β-related pathways [35]. Here, GLP1R is linked to major depressive disorder.